KROS — KEROS THERAPEUTICS INC

Ownership history in EJF Capital LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which EJF Capital LP reported a position in KEROS THERAPEUTICS INC (KROS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2025 Q4)
Avg. % of fund
0.17%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 15,000 — — 0.17% $305K $20.36
% of Fund (quarterly)    KROS price (monthly, adj. close)

Other funds also holding KROS

As of 2025 Q4 — sorted by position size

Rangeley Capital, LLC 1.64% Madison Avenue Partners, LP 3Y 0.72% ORBIMED ADVISORS LLC 3Y 7Y 0.33% Nantahala Capital Management, LLC 3Y 7Y 0.24% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.21% Quantedge Capital Pte Ltd 3Y 0.19% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.18% Nantahala Capital Management, LLC 3Y 7Y 0.17% PDT Partners, LLC 3Y 7Y 0.15% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.11%
← Back to EJF Capital LP Holdings